Skip to main content

Table 2 Inhibitory activities of crude extracts and isolated compounds against P. falciparum, T. brucei rhodesiense, and M. tuberculosis

From: Isolation of bioactive compounds from medicinal plants used in traditional medicine: Rautandiol B, a potential lead compound against Plasmodium falciparum

Compounds (μM)

Crude Extracts (μg/mL)

MTB H37Rv (MIC μM)

T. br (IC50 μM)

P. f (IC50 μM)

TM4/8.2

K1CB1

ABDCM

> 20

3.04 ± 0.27

2.99 ± 0.59

SR −0.9

2.67 ± 1.05

SR −1.01

KEOH

> 20

18.14 ± 1.34

> 50

> 50

CEOH

> 20

22.89 ± 1.29

> 50

> 50

1

> 20

8.74 ± 0.49

SR - 3.3

> 50

> 50

2

> 20

8.91 ± 0.03

SR - 4.52

> 50

> 50

3

> 20

> 100

> 100

> 100

4

> 20

> 100

> 100

> 100

5

> 62.1

–

> 31.0

> 31.0

6

> 64.9

–

> 32.5

> 32.5

7

> 34.4

–

> 17.2

> 17.2

10

> 64.7

–

> 32.3

> 32.3

11

> 62.0

17.01 ± 1.83

> 31.0

> 31.0

13

> 56.9

–

> 28.5

> 28.5

14

> 59.9

18.65 ± 3.20

> 29.6

> 29.6

15

> 56.8

4.87 ± 0.49

SR > 5.83

> 28.4

> 28.4

16

> 56.4

–

> 28.2

> 28.2

19

> 56.8

–

> 28.4

> 28.4

20

> 52.3

7.51 ± 0.17

> 26.2

> 26.2

21

> 55.2

8.63 ± 1.14

> 27.6

> 27.6

22

> 61.7

–

> 30.9

> 30.9

24

> 20

23.54 ± 1.59

0.40 ± 0.07

SR −108

0.74 ± 0.29

SR −133

Isoniazid

0.02

–

–

–

Rifampin

0.08

–

–

–

Cycloguanil

–

–

0.076 ± 0.016

10.7 ± 1.62

Pyrimethamine

–

 

0.095 ± 0.02

23.21 ± 2.24

Pentamidine

–

0.007 ± 0.00004

–

–

  1. Abbreviations: MTB Mycobacterium tuberculosis, T. br Trypanosoma brucei rhodesience, P. f Plasmodium falciparum, SR Safety ratio